- Home
- VRNS vs INSP Comparison
VRNS vs INSP Comparison
Compare VRNS & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNS
- INSP
- Stock Information
- Founded
- VRNS 2004
- INSP 2007
- Country
- VRNS United States
- INSP United States
- Employees
- VRNS N/A
- INSP N/A
- Industry
- VRNS Computer Software: Prepackaged Software
- INSP Medical/Dental Instruments
- Sector
- VRNS Technology
- INSP Health Care
- Exchange
- VRNS Nasdaq
- INSP Nasdaq
- Market Cap
- VRNS 5.0B
- INSP 4.4B
- IPO Year
- VRNS 2014
- INSP 2018
- Fundamental
- Price
- VRNS $40.39
- INSP $150.21
- Analyst Decision
- VRNS Buy
- INSP Buy
- Analyst Count
- VRNS 18
- INSP 10
- Target Price
- VRNS $57.53
- INSP $222.20
- AVG Volume (30 Days)
- VRNS 1.6M
- INSP 473.9K
- Earning Date
- VRNS 05-06-2025
- INSP 05-05-2025
- Dividend Yield
- VRNS N/A
- INSP N/A
- EPS Growth
- VRNS N/A
- INSP N/A
- EPS
- VRNS N/A
- INSP 1.75
- Revenue
- VRNS $550,950,000.00
- INSP $802,804,000.00
- Revenue This Year
- VRNS $14.93
- INSP $20.65
- Revenue Next Year
- VRNS $16.19
- INSP $17.49
- P/E Ratio
- VRNS N/A
- INSP $85.83
- Revenue Growth
- VRNS 10.38
- INSP 28.49
- 52 Week Low
- VRNS $36.53
- INSP $123.00
- 52 Week High
- VRNS $60.58
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- VRNS 46.53
- INSP 44.54
- Support Level
- VRNS $37.08
- INSP $137.97
- Resistance Level
- VRNS $42.13
- INSP $152.25
- Average True Range (ATR)
- VRNS 1.89
- INSP 10.34
- MACD
- VRNS 0.15
- INSP 0.57
- Stochastic Oscillator
- VRNS 66.10
- INSP 55.92
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.